A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

636

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

March 10, 2021

Study Completion Date

March 31, 2021

Conditions
Type 2 Diabetes
Interventions
DRUG

Tirzepatide

Administered SC

DRUG

Dulaglutide

Administered SC

Trial Locations (46)

6008898

Keiseikai Kajiyama Clinic, Kyoto

260 0804

Akaicho Clinic, Chiba

261-0004

Medical corporation THY Tokuyama Clinic, Chiba Mihama-ku

737-0023

National Hospital Organization Kure Medical Center, Kure

066-0032

Hasegawa Medical Clinic, Chitose

060-0001

Yuri Ono Clinic, Sapporo

662-0971

Watanabe Naika Clinic, Nishinomiya

663-8113

Hayashi Clinic, Nishinomiya

311-0113

Naka Memorial Clinic, Naka

253-0044

Hayashi Diabetes Internal Medicine Clinic, Chigasaki-sh

243-0432

Matoba Diabetes Clinic, Ebina

247-0056

Takai Naika Clinic, Kamakura

211-8510

Kanto Rosai Hospital, Kawasaki

235-0045

H.E.C. Science Clinic, Yokohama

565-0853

Medical Corporation Heishinkai OCROM Clinic, Suita-shi

569-1096

Takatsuki Red Cross Hospital, Takatsuki

560-0082

Senrichuo Ekimae Clinic, Toyonaka

350 0581

Asano Clinic, Kawagoe

332-8558

Kawaguchi General Hospital, Kawaguchi

329-0433

Wakakusa Clinic, Shimotsuke

123 0845

Seiwa Clinic, Adachi-ku

102-0082

HDC Atlas Clinic, Chiyoda City

101 0041

Meiwa Hospital, Chiyodaku

103 0002

Asahi Life Foundation Adult Disease Research Center, Chuo-ku

103-0025

Nihonbashi Sakura Clinic, Chuo-ku

103-0027

Tokyo-Eki Center-building Clinic, Chuo-ku

103-0028

Medical Corporation Chiseikai Tokyo Center Clinic, Chuo-ku

104 0031

Tokyo aSBo Clinic, Chuo-ku

104-0031

Fukuwa Clinic, Chuo-ku

108-0075

IHL Shinagawa East One Medical Clinic, Minato-ku

143-0015

Sato Medical Clinic, Ootaku

169-0073

Shinjuku Research Park Clinic, Shinjuku

160 0008

Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku

160 0022

Tomonaga Clinic, Shinjuku-ku

166-0003

Shinei Clinic, Suginami

171-0021

Ikebukuro Metropolitan Clinic, Toshima-ku

810-0006

Futata Tetsuhiro Clinic, Fukuoka

732-0057

JR Hiroshima Hospital, Hiroshima

861-8039

Yoshimura Clinic, Kumamoto

701-1192

OKAYAMA Medical Center, Okayama

530-0001

AMC Nishiumeda Clinic, Osaka

538-0044

Kitada Clinic, Osaka

559-0011

Nanko Clinic, Osaka

870-0039

Abe Clinic, Ōita

424-0855

Suruga Clinic, Shizuoka

232-0064

Yokohama Minoru Clinic, Yokohama

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03861052 - A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes | Biotech Hunter | Biotech Hunter